Acute respiratory distress syndrome (ARDS) is an acute inflammatory lung condition characterised by diffuse alveolar damage, increased capillary permeability and severe hypoxaemia refractory to oxygen ...

CHICAGO -- Classifying inflammatory subphenotypes of acute respiratory distress syndrome (ARDS) with bedside lab testing was feasible and showed differences in 60-day mortality, according to a ...

In a new report posted online in the American Journal of Respiratory and Critical Care Medicine, a global consensus conference of 32 critical care experts with broad international representation and ...

An initial trial suggests that a new drug, originally developed for use with cancer patients, could improve the survival of patients with acute respiratory distress syndrome (ARDS). The patients in ...

As for whether the trial established that simvastatin is beneficial, the trial was stopped early because of a low likelihood of reaching prespecified stopping criteria, as a result of decreasing ...

In experiments with ARDS model mice, researchers from Japan found that basophils, a type of white blood cells, release interleukin-4, a signaling molecule that suppresses inflammatory neutrophils ...

In a recent study published in PLoS ONE, researchers evaluated the outcomes and identified risk factors associated with the development of ARDS (acute respiratory distress syndrome) after SARS-CoV-2 ...

In a new report posted online in the American Journal of Respiratory and Critical Care Medicine, a global consensus conference of 32 critical care experts with broad international representation and ...

The acute respiratory distress syndrome market is expected to grow, driven by factors such as an increase in the incident pool, expected entry of emerging therapies such as MultiStem (HLCM051) ...

Basophils, a type of white blood cell, promote recovery from acute respiratory distress syndrome (ARDS) in mice, according to researchers at Science Tokyo. In a mouse model of ARDS, basophils were ...